Barry A. Murrer
Impact in
- Oncology top 1%
- Metal complexes synthesis and properties
- Drug Transport and Resistance Mechanisms
- Organic Chemistry top 1%
- Ferrocene Chemistry and Applications
- Organometallic Complex Synthesis and Catalysis
Papers in
- Oncology 29
- Metal complexes synthesis and properties 27
- Drug Transport and Resistance Mechanisms 4
-
- Ferrocene Chemistry and Applications 10
- Organometallic Complex Synthesis and Catalysis 5
- Co-authors
- Michael J. Abrams (5 shared papers)Kenneth R. Harrap (13 shared papers)Lloyd R. Kèlland (11 shared papers)Prakash Mistry (10 shared papers)Lloyd R. Kelland (6 shared papers)C. F. J. Barnard (10 shared papers)Phyllis M. Goddard (7 shared papers)Florence I. Raynaud (7 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (5 papers)Tetrahedron Letters (3 papers)Chemical Communications (2 papers)Journal of Medicinal Chemistry (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Barry A. Murrer
49 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 110
- Oncology 1.9k
- Organic Chemistry 1.3k
- Inorganic Chemistry 438
- Virology 101
- Catalysis 129
Countries citing papers authored by Barry A. Murrer
This map shows the geographic impact of Barry A. Murrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Murrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Murrer more than expected).
Fields of papers citing papers by Barry A. Murrer
This network shows the impact of papers produced by Barry A. Murrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Murrer. The network helps show where Barry A. Murrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry A. Murrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 237 | |
| 2 | 1995 | 224 | |
| 3 | 1992 | 202 | |
| 4 | Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. | 1993 | 201 |
| 5 | 2022 | 174 | |
| 6 | 1998 | 172 | |
| 7 | 1998 | 157 | |
| 8 | Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. | 1992 | 155 |
| 9 | A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. | 1994 | 116 |
| 10 | 1997 | 111 | |
| 11 | cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. | 1997 | 106 |
| 12 | 1996 | 103 | |
| 13 | Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. | 1992 | 102 |
| 14 | Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473). | 1998 | 99 |
| 15 | 1995 | 84 | |
| 16 | 1981 | 84 | |
| 17 | 1997 | 82 | |
| 18 | 1993 | 75 | |
| 19 | 1995 | 74 | |
| 20 | 1995 | 71 |
About Barry A. Murrer
Barry A. Murrer is a scholar working on Oncology, Organic Chemistry, Materials Chemistry, Hematology and Inorganic Chemistry, having authored 50 papers that have together received 3.3k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (27 papers), Ferrocene Chemistry and Applications (10 papers), Lanthanide and Transition Metal Complexes (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Asymmetric Hydrogenation and Catalysis (6 papers), Organometallic Complex Synthesis and Catalysis (5 papers), Chemical Reactions and Isotopes (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Oncology (1.9k citations), Organic Chemistry (1.3k citations), Inorganic Chemistry (438 citations), Virology (101 citations) and Catalysis (129 citations). Barry A. Murrer has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Michael J. Abrams, Kenneth R. Harrap, Lloyd R. Kèlland, Prakash Mistry, Lloyd R. Kelland, C. F. J. Barnard, Phyllis M. Goddard, Florence I. Raynaud, John M. Brown and G Abel. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Tetrahedron Letters, Chemical Communications, Journal of Medicinal Chemistry and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.